Aaron Rubinstein, MD
Hand Surgery · Linden, NJNPI 1730574823
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (56.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Arthrex accounts for 78.0% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2021 at $10,358 and has fallen 99.1% since, to $93 in 2025.
Across 51 payments — averaging $345.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$14K
- Exactech, Inc.$1K
- Medartis Inc.$798
- Seapearl East, Inc$739
- Stryker$344
- Endo Pharmaceuticals Inc.$148
- plus $399 from 8 others
What the payments were for
- Grants$10,00057%
- Travel & lodging$2,56515%
- Food & beverage$2,64015%
- Education$2,40014%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 20 | $13,732 |
| Exactech, Inc. | 3 | $1,445 |
| Medartis Inc. | 7 | $798 |
| Seapearl East, Inc | 5 | $739 |
| Stryker | 4 | $344 |
| Endo Pharmaceuticals Inc. | 3 | $148 |
| Johnson & Johnson | 1 | $142 |
| Skeletal Dynamics Inc | 1 | $129 |
| Axogen | 2 | $34 |
| ANI Pharmaceuticals, Inc. | 1 | $24 |
| Endo USA, Inc. | 1 | $19 |
| Harmony Biosciences LLC | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Mid-atlantic Surgical Systems, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,605 in reported general payments places this provider in the 85th percentile of 87 hand surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naproxen | 119 | $695 |
| Methylprednisolone | 75 | $508 |
| Ibuprofen | 16 | $64 |
Paid to pharmacies, not to this prescriber.
Other hand surgery in Linden
- Charles LeinberryEgg Harbor Twp$3.1M
- John CapoJersey City$1.1M
- Virak TanNewark$711K
- Gary PessEatontown$212K
- Mark RekantCherry Hill$209K
- Teddy AtikEatontown$37K
- Bishoy SaadJersey City$33K
- Genghis NiverFlorham Park$27K
- Michael VosbikianNewark$26K
- Linda ChaoCape May Court House$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.